| INTRODUC TI ONCorneal transplantation is the most common form of tissue grafting worldwide. 1 When performed on an uninflamed and nonvascularized host bed, the graft survival rate exceeds 90%. 2 However, inflammation and vascularization of the host bed disrupt the cornea's relatively tolerant immune microenvironment, and graft survival rates fall to ≈50% despite maximum immunosuppression in highrisk recipients. 3-5 Immune rejection is the leading cause of corneal graft failure. 6 Corneal endothelial cells (CEnCs) are the target of the effector immune response mediated primarily by graft-targeting CD4 + interferon gamma (IFNγ + ) T helper type 1 (Th1) cells. 7,8 When the CEnC count decreases beyond a certain threshold, they are no longer capable of maintaining corneal graft transparency and the graft fails. 9,10 Substantial progress has been made in determining the mechanisms by which host factors, such as recipient bed vascularity and inflammation, influence the immune response to corneal allografts. 11-15 Forkhead box protein 3 (Foxp3)-positive regulatory T cells (Tregs) are a subset of CD4 + T cells that play a critical role in maintaining immune tolerance. 16 Studies performed by our laboratory 17-24 and others 25-27 indicate the critical contribution of Foxp3 + Tregs to immune tolerance in the setting of corneal transplantation.The functional competence of corneal endothelial cells (CEnCs) is critical for survival of corneal allografts, but these cells are often targets of the immune response mediated by graft-attacking effector T cells. Although regulatory T cells (Tregs) have been studied for their role in regulating the host's alloimmune response towards the graft, the cytoprotective function of these cells on CEnCs has not been investigated. The aim of this study was to determine whether Tregs suppress effector T cell-mediated and inflammatory cytokine-induced CEnC death, and to elucidate the mechanism by which this cytoprotection occurs. Using 2 well-established models of corneal transplantation (low-risk and high-risk models), we show that Tregs derived from low-risk graft recipients have a superior capacity in protecting CEnCs against effector T cellmediated and interferon-γ and tumor necrosis factor-α-induced cell death compared to Tregs derived from high-risk hosts. We further demonstrate that the cytoprotective function of Tregs derived from low-risk hosts occurs independently of direct cell-cell contact and is mediated by the immunoregulatory cytokine IL-10. Our study is the first to report that Tregs provide cytoprotection for CEnCs through secretion of IL-10, indicating potentially novel therapeutic targets for enhancing CEnC survival following corneal transplantation.
K E Y W O R D Sanimal models: murine, basic (laboratory) research/science, corneal transplantation/ ophthalmology, immune regulation, T cell biology, tolerance